Arcus Biosciences, Inc.
$24.65
$0.33 (+1.36%)
$24.18Day Range$25.28
Key Statistics
Market Cap
$3.14B
Shares Outstanding
127.3M
Primary Exchange
XNYS
Currency
USD
Type
CS
IPO Date
Mar 15, 2018
Round Lot
100
Locale
US
Trading Data
Day Open
$24.79
Day High
$25.28
Day Low
$24.18
Volume
2.30M
VWAP
$24.74
Prev Close
$24.32
Transactions
--
Acc. Volume
--
About Arcus Biosciences, Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
PHARMACEUTICAL PREPARATIONSSIC 2834601 employees3928 POINT EDEN WAY, HAYWARD, CA, 94545(510) 694-6200IPO Mar 15, 2018US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001724521
- Composite FIGI
- BBG00DQD26W3
- Share Class FIGI
- BBG00DQD2751
- Ticker Root
- RCUS
- SIC Code
- 2834
About Arcus Biosciences, Inc. (RCUS) Stock
Arcus Biosciences, Inc. (RCUS) closed the 2026-09-16 session at $24.65, up 1.36% versus the previous close (+0.33). The stock opened at $24.79 and traded between $24.18 and $25.28 during that session. Session trading volume was 2.3M shares. The volume-weighted average price (VWAP) is $24.74.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
Arcus Biosciences, Inc. has a market capitalization of $3.14 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. RCUS is listed on the XNYS exchange. The company employs approximately 601 people. Arcus Biosciences, Inc. is headquartered in HAYWARD, CA. The recorded listing date is 2018-03-15.
On this page you can find market RCUS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.